- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07951242
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of a Children's Fiber Blend on Digestive Health and Gut Microbiome Composition in Children
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of LOAM Kids Gut Starter Fiber Formula on Digestive Health and Gut Microbiome Composition in Children
This study evaluates the impact of a fiber blend supplement on gastrointestinal symptoms and the gut microbiome in children aged 3-6 with a history or irregular stooling.
연구 개요
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Bryce Jarman
- 전화번호: 323-325-1327
- 이메일: bryce@loamscience.com
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Male or female child, aged 3-6 years (inclusive) at the time of enrollment.
- Caregiver reports the child consumes few vegetables, whole fruit, whole grains, or legumes per week (fewer than two per day on average), consistent with this study's operational definition of low dietary fiber intake.
- Caregiver reports infrequent or difficult bowel movements (constipation) in the child over the past four weeks
- Caregiver reports the child has experienced excess gas, or bloating, over the past four weeks
- Caregiver is willing and able to administer the study product to the child once daily with a meal for 4 weeks, complete digital questionnaires at Baseline, Weeks 1, 2, 3, and End of Study on behalf of the enrolled child, and to facilitate at-home microbiome stool sample collection at Baseline and End of Study and return samples per provided instructions.
- Child is generally healthy, without any acute or chronic condition that would preclude safe participation as determined by caregiver report.
- Caregiver is willing to maintain the child's current diet, sleep patterns, and activity levels throughout the study duration, and to avoid introducing new fiber supplements or probiotic/prebiotic products during the study period.
- Caregiver and child reside in the United States.
- Caregiver is willing and able to provide informed consent; child assent will be obtained where age-appropriate and consistent with IRB requirements.
Exclusion Criteria:
- Known milk allergy, dairy allergy, lactose intolerance, or any known sensitivity to milk-derived products. (The study product's active formulation contains a milk allergen.)
- Child is currently breastfeeding.
- Known allergy or sensitivity to any component of the study product.
- Currently receiving anticoagulant or antiplatelet medications (e.g., warfarin), due to potential interaction with Vitamin K2 contained in the study product.
- Diagnosis of, or current treatment for, any gastrointestinal disease or disorder, including but not limited to: inflammatory bowel disease (IBD), Crohn's disease, ulcerative colitis, celiac disease, or diagnosed functional gastrointestinal disorders requiring medical management.
- Use of any prescription or over-the-counter laxative, stool softener, antidiarrheal medication, or fiber supplement on a regular basis (≥3 times per week) in the 4 weeks prior to enrollment, or intent to use during the study.
- Use of oral antibiotics or antifungals within 4 weeks prior to enrollment, or anticipated use during the study period.
- Use of any probiotic or prebiotic supplement (other than those naturally occurring in diet) in the 4 weeks prior to enrollment, or intent to use during the study.
- Significant acute illness, including fever, acute gastrointestinal infection, or other acute medical condition at the time of enrollment, or any chronic medical condition, developmental condition, or disability that, in the caregiver's judgment or per clinical guidance, would prevent the child from safely adhering to the study protocol.
- Any planned surgical procedure during the 4-week study period.
- Participation in another research study currently or within the past 30 days, or planned participation in any other research study during this study's duration.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 다른
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 삼루타
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
위약 비교기: 위약
|
Color and taste matched placebo. |
|
실험적: Fiber Blend
|
This fiber blend contains a blend of Bifidogenic fibers and HMOs |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Stool Frequency
기간: Baseline, Week 1, Week 2, Week 3, End of Study (Week 4)
|
Caregiver reported number of bowel movements per week |
Baseline, Week 1, Week 2, Week 3, End of Study (Week 4)
|
|
Stool Consistency
기간: Baseline, Week 1, Week 2, Week 3, End of Study (Week 4)
|
Caregiver reported stool consistency using the pediatric-adapted Bristol Stool Scale (one-seven, with one indicating hard lumpy stools and seven indicating soft liquid stools) |
Baseline, Week 1, Week 2, Week 3, End of Study (Week 4)
|
|
Digestive Comfort
기간: Baseline, Week 1, Week 2, Week 3, End of Study (Week 4)
|
Digestive comfort assessed using a visual analog scale (one-five, with one being very bad and five being very good) |
Baseline, Week 1, Week 2, Week 3, End of Study (Week 4)
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Microbiome Composition
기간: Baseline, End of Study (Week 4)
|
Determined using shotgun metagenomic sequencing |
Baseline, End of Study (Week 4)
|
|
Gas and Bloating
기간: Baseline, Week 1, Week 2, Week 3, End of Study (Week 4)
|
Gas and bloating assessed using a visual analog scale (one-five, with one being never bloated and five being always bloated) |
Baseline, Week 1, Week 2, Week 3, End of Study (Week 4)
|
공동 작업자 및 조사자
스폰서
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- LOA005
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
Data is proprietary
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .